Amizuka N, Lee H S, Kwan M Y, Arazani A, Warshawsky H, Hendy G N, Ozawa H, White J H, Goltzman D
Department of Medicine, McGill University, Montreal, Quebec, Canada.
Endocrinology. 1997 Jan;138(1):469-81. doi: 10.1210/endo.138.1.4845.
The kidney is the major site of expression of the PTH/PTH-related peptide receptor (PTHR) gene. Previously we have shown that the PTHR gene is expressed from two promoters in kidney, an upstream kidney-specific promoter (P1) and a downstream promoter (P2) that is active in a wide variety of tissues. Here, we have used immunohistochemical and transcript-specific in situ hybridization techniques to map the expression of the PTHR gene and protein and to determine the distribution of P1- and P2-driven messenger RNAs in renal tissue. Immunohistochemical and immunoelectron microscopic analysis showed that PTHR protein is expressed on both basolateral and luminal membranes of proximal tubular epithelial cells, strongly suggesting a bipolar mode of action of PTH. Receptor protein also was detected on the surface of glomerular podocytes. Strikingly, immunoelectron microscopic analysis showed that endothelial cells of the peritubular vasculature, but not the glomerular vasculature, contain high levels of PTHR protein. We found that both P1 and P2 are expressed at moderate levels in both cortical and medullary epithelial cells of nephrons, correlating well with the immunohistochemical localization of PTHR protein. However, although abundant transcripts were detected in peritubular endothelial cells with P1-specific and coding sequence probes, P2-specific expression was not observed in these cells. These results provide evidence that the physiological effects of PTH- and/or PTH-related peptide on renal tubular function may be mediated not only through direct effects on epithelial cells but also indirectly through endothelial cell-based signaling. In addition to expression in vascular endothelial cells, high levels of P1-specific, but not P2-specific, PTHR messenger RNA were detected in vascular smooth muscle. Taken together, these experiments provide evidence for strong PTHR gene expression in renal vascular tissues. Moreover, given that previous studies have shown that P2, but not P1, is active in other tissues with an abundant vasculature, our results suggest that regulation of PTHR gene expression in renal vascular tissue is distinct from that of other organs.
肾脏是甲状旁腺激素/甲状旁腺激素相关肽受体(PTHR)基因表达的主要部位。此前我们已表明,PTHR基因在肾脏中由两个启动子表达,一个是上游肾脏特异性启动子(P1),另一个是下游启动子(P2),后者在多种组织中具有活性。在此,我们运用免疫组织化学和转录本特异性原位杂交技术,来绘制PTHR基因和蛋白的表达图谱,并确定P1和P2驱动的信使核糖核酸在肾组织中的分布。免疫组织化学和免疫电子显微镜分析显示,PTHR蛋白在近端肾小管上皮细胞的基底外侧膜和管腔膜上均有表达,这有力地表明了甲状旁腺激素具有双极作用模式。在肾小球足细胞表面也检测到了受体蛋白。引人注目的是,免疫电子显微镜分析显示,肾小管周围血管的内皮细胞而非肾小球血管的内皮细胞含有高水平的PTHR蛋白。我们发现,P1和P2在肾单位的皮质和髓质上皮细胞中均有中等水平的表达,这与PTHR蛋白的免疫组织化学定位密切相关。然而,尽管用P1特异性和编码序列探针在肾小管周围内皮细胞中检测到了丰富的转录本,但在这些细胞中未观察到P2特异性表达。这些结果提供了证据,表明甲状旁腺激素和/或甲状旁腺激素相关肽对肾小管功能的生理作用可能不仅通过对上皮细胞的直接作用来介导,还可能通过基于内皮细胞的信号传导间接介导。除了在血管内皮细胞中的表达外,在血管平滑肌中检测到了高水平的P1特异性而非P2特异性的PTHR信使核糖核酸。综上所述,这些实验为PTHR基因在肾血管组织中的强烈表达提供了证据。此外,鉴于先前的研究表明P2而非P1在其他血管丰富的组织中具有活性,我们的结果表明肾血管组织中PTHR基因表达的调控与其他器官不同。